Holy Cross Women's Hospital
Fort Lauderdale, Florida, 33334, United States
NCT Number: NCT06885099
The objective of the study is to demonstrate that the FemPulse System can be used as indicated
Looking for future studies?
Notify Me21 year and older
Female
Interventional
Not applicable
Fort Lauderdale, Florida, 33334, United States
The objective of the study is to demonstrate that the FemPulse System can be used as indicated in the Patient and Clinician Instructions for Use (IFU), as applicable.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Exclusion criteria
Subjects to receive the FemPulse System consisting of a non-implanted, vaginal electrical stimulation device (Ring) and other patient accessories.
Time frame: 2 days
A survery will be conducted to determine the overall usability of the system
FemPulse Corporation
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736560
Ejaculation Abnormal, Female Urogenital Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07728747
Detrusor Overactivity, Female Urogenital Diseases
Gaziantep, Şahinbey, Turkey (Türkiye)
View Trial DetailsNCT07206446
Alzheimer Disease, Brain Diseases
Galway, Ireland
View Trial DetailsNCT05702294
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Birmingham, United Kingdom
View Trial Details